[
    {
        "source": {
            "primary_name": "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
            "candidates": [
                "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
                "Anti-TNF Monoclonal Antibodies",
                "TNF Inhibitors",
                "Monoclonal Antibodies against TNF",
                "TNF Blockers"
            ],
            "entity_name": "Anti-TNF monoclonal antibodies",
            "type": "Drug",
            "description": "Monoclonal antibodies that inhibit tumor necrosis factor (TNF), used in the treatment of inflammatory bowel disease (IBD).",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Fc Gamma Receptor",
            "candidates": [
                "Fc Gamma Receptor",
                "Fc\u03b3 Receptor",
                "Fc\u03b3R",
                "Fc Receptors",
                "Receptors for Immunoglobulin G"
            ],
            "entity_name": "Fc\u03b3-receptor (Fc\u03b3R)",
            "type": "Protein",
            "description": "Receptors that bind to the Fc region of immunoglobulin G (IgG) and are involved in the immune response.",
            "is_ambiguous": false
        },
        "relationship": "interacts with",
        "description": "Anti-TNF monoclonal antibodies act through Fc\u03b3-receptor (Fc\u03b3R) signalling to promote repolarisation of proinflammatory intestinal macrophages."
    },
    {
        "source": {
            "primary_name": "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
            "candidates": [
                "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
                "Anti-TNF Monoclonal Antibodies",
                "TNF Inhibitors",
                "Monoclonal Antibodies against TNF",
                "TNF Blockers"
            ],
            "entity_name": "Anti-TNF monoclonal antibodies",
            "type": "Drug",
            "description": "Monoclonal antibodies that inhibit tumor necrosis factor (TNF), used in the treatment of inflammatory bowel disease (IBD).",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Interleukin-10",
            "candidates": [
                "Interleukin-10",
                "IL-10",
                "Cytokine IL-10",
                "Interleukin 10"
            ],
            "entity_name": "Interleukin-10 (IL-10)",
            "type": "Protein",
            "description": "A cytokine with anti-inflammatory properties, playing a key role in regulating immune responses.",
            "is_ambiguous": false
        },
        "relationship": "modulates",
        "description": "Anti-TNF therapy increased macrophage IL-10 production in an Fc\u03b3R-dependent manner."
    },
    {
        "source": {
            "primary_name": "Interleukin-10",
            "candidates": [
                "Interleukin-10",
                "IL-10",
                "Cytokine IL-10",
                "Interleukin 10"
            ],
            "entity_name": "Interleukin-10 (IL-10)",
            "type": "Protein",
            "description": "A cytokine with anti-inflammatory properties, playing a key role in regulating immune responses.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "CD206 Positive Regulatory Macrophages",
            "candidates": [
                "CD206 Positive Regulatory Macrophages",
                "CD206+ Regulatory Macrophages",
                "CD206+ Macrophages",
                "Regulatory Macrophages",
                "CD206 Macrophages"
            ],
            "entity_name": "CD206+ regulatory macrophages",
            "type": "Protein",
            "description": "A subset of macrophages characterized by CD206 expression, associated with anti-inflammatory functions.",
            "is_ambiguous": false
        },
        "relationship": "induces",
        "description": "IL-10 signalling in macrophages is critical for the induction of CD206+ regulatory macrophages."
    },
    {
        "source": {
            "primary_name": "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
            "candidates": [
                "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
                "Anti-TNF Monoclonal Antibodies",
                "TNF Inhibitors",
                "Monoclonal Antibodies against TNF",
                "TNF Blockers"
            ],
            "entity_name": "Anti-TNF monoclonal antibodies",
            "type": "Drug",
            "description": "Monoclonal antibodies that inhibit tumor necrosis factor (TNF), used in the treatment of inflammatory bowel disease (IBD).",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "CD206 Positive Regulatory Macrophages",
            "candidates": [
                "CD206 Positive Regulatory Macrophages",
                "CD206+ Regulatory Macrophages",
                "CD206+ Macrophages",
                "Regulatory Macrophages",
                "CD206 Macrophages"
            ],
            "entity_name": "CD206+ regulatory macrophages",
            "type": "Protein",
            "description": "A subset of macrophages characterized by CD206 expression, associated with anti-inflammatory functions.",
            "is_ambiguous": false
        },
        "relationship": "induces",
        "description": "Anti-TNF therapy causes differentiation of macrophages to a more regulatory CD206+ phenotype."
    },
    {
        "source": {
            "primary_name": "Interleukin-10",
            "candidates": [
                "Interleukin-10",
                "IL-10",
                "Cytokine IL-10",
                "Interleukin 10"
            ],
            "entity_name": "Interleukin-10 (IL-10)",
            "type": "Protein",
            "description": "A cytokine with anti-inflammatory properties, playing a key role in regulating immune responses.",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "CD4 Positive CD45R High T-Cells",
            "candidates": [
                "CD4 Positive CD45R High T-Cells",
                "CD4+CD45Rbhigh T-cells",
                "CD4+ T-Cells",
                "CD45Rbhigh T-Cells",
                "CD4 T-Cells"
            ],
            "entity_name": "CD4+CD45Rbhigh T-cells",
            "type": "Protein",
            "description": "A subset of T-cells that are involved in the immune response, used in the study's model.",
            "is_ambiguous": false
        },
        "relationship": "does not influence",
        "description": "IL-10 signalling in macrophages but not T cells was critical for the induction of CD206+ regulatory macrophages."
    },
    {
        "source": {
            "primary_name": "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
            "candidates": [
                "Anti-Tumor Necrosis Factor Monoclonal Antibodies",
                "Anti-TNF Monoclonal Antibodies",
                "TNF Inhibitors",
                "Monoclonal Antibodies against TNF",
                "TNF Blockers"
            ],
            "entity_name": "Anti-TNF monoclonal antibodies",
            "type": "Drug",
            "description": "Monoclonal antibodies that inhibit tumor necrosis factor (TNF), used in the treatment of inflammatory bowel disease (IBD).",
            "is_ambiguous": false
        },
        "target": {
            "primary_name": "Inflammatory Bowel Disease",
            "candidates": [
                "Inflammatory Bowel Disease",
                "Inflammatory Bowel Diseases",
                "IBD",
                "Crohn's Disease",
                "Ulcerative Colitis",
                "IBD Subtypes"
            ],
            "entity_name": "Inflammatory bowel disease (IBD)",
            "type": "Disease",
            "description": "A group of inflammatory conditions of the gastrointestinal tract, primarily including Crohn's disease and ulcerative colitis.",
            "is_ambiguous": false
        },
        "relationship": "treats",
        "description": "The therapeutic efficacy of anti-TNF in resolving intestinal inflammation is critically dependent on IL-10 signalling in macrophages."
    }
]